Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 29% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 286.99 | 170 / 170 | 79% | 1.82 | 363 / 459 |
thymus | 100% | 211.25 | 652 / 653 | 79% | 1.30 | 478 / 605 |
bladder | 100% | 302.76 | 21 / 21 | 79% | 1.83 | 397 / 504 |
ovary | 100% | 195.62 | 180 / 180 | 78% | 1.45 | 337 / 430 |
kidney | 100% | 175.93 | 89 / 89 | 77% | 1.54 | 693 / 901 |
skin | 100% | 465.99 | 1809 / 1809 | 76% | 1.61 | 359 / 472 |
breast | 100% | 299.58 | 459 / 459 | 74% | 1.74 | 829 / 1118 |
esophagus | 100% | 279.14 | 1444 / 1445 | 74% | 1.60 | 135 / 183 |
lung | 98% | 171.23 | 567 / 578 | 73% | 1.57 | 844 / 1155 |
intestine | 99% | 249.59 | 961 / 966 | 67% | 1.50 | 353 / 527 |
pancreas | 97% | 103.56 | 318 / 328 | 69% | 1.12 | 122 / 178 |
stomach | 96% | 138.52 | 344 / 359 | 63% | 1.40 | 180 / 286 |
prostate | 100% | 270.53 | 245 / 245 | 35% | 0.55 | 178 / 502 |
adrenal gland | 98% | 179.41 | 254 / 258 | 30% | 0.51 | 70 / 230 |
liver | 89% | 99.30 | 201 / 226 | 39% | 0.72 | 158 / 406 |
brain | 75% | 74.85 | 1971 / 2642 | 37% | 0.58 | 262 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2.52 | 29 / 29 |
spleen | 100% | 229.63 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 277.98 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 223.83 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 158.10 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 113.69 | 809 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 1.88 | 39 / 45 |
peripheral blood | 41% | 57.48 | 382 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 26% | 0.44 | 21 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0006281 | Biological process | DNA repair |
GO_0000012 | Biological process | single strand break repair |
GO_0051106 | Biological process | positive regulation of DNA ligation |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0006302 | Biological process | double-strand break repair |
GO_0006974 | Biological process | DNA damage response |
GO_0045191 | Biological process | regulation of isotype switching |
GO_0006457 | Biological process | protein folding |
GO_0071168 | Biological process | protein localization to chromatin |
GO_0010717 | Biological process | regulation of epithelial to mesenchymal transition |
GO_0007566 | Biological process | embryo implantation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0003906 | Molecular function | DNA-(apurinic or apyrimidinic site) endonuclease activity |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0000166 | Molecular function | nucleotide binding |
GO_0008408 | Molecular function | 3'-5' exonuclease activity |
GO_0160002 | Molecular function | ADP-D-ribose modification-dependent protein binding |
GO_0140713 | Molecular function | histone chaperone activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004520 | Molecular function | DNA endonuclease activity |
GO_0072572 | Molecular function | poly-ADP-D-ribose binding |
GO_0005515 | Molecular function | protein binding |
Gene name | APLF |
Protein name | Aprataxin and PNKP like factor Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1) |
Synonyms | PALF C2orf13 XIP1 |
Description | FUNCTION: Histone chaperone involved in single-strand and double-strand DNA break repair . Recruited to sites of DNA damage through interaction with branched poly-ADP-ribose chains, a polymeric post-translational modification synthesized transiently at sites of chromosomal damage to accelerate DNA strand break repair reactions . Following recruitment to DNA damage sites, acts as a histone chaperone that mediates histone eviction during DNA repair and promotes recruitment of histone variant MACROH2A1 . Also has a nuclease activity: displays apurinic-apyrimidinic (AP) endonuclease and 3'-5' exonuclease activities in vitro . Also able to introduce nicks at hydroxyuracil and other types of pyrimidine base damage . Together with PARP3, promotes the retention of the LIG4-XRCC4 complex on chromatin and accelerate DNA ligation during non-homologous end-joining (NHEJ) . Also acts as a negative regulator of cell pluripotency by promoting histone exchange (By similarity). Required for the embryo implantation during the epithelial to mesenchymal transition in females (By similarity). . |
Accessions | ENST00000303795.9 F8WET0 ENST00000445692.5 Q8IW19 E9PRH6 ENST00000529851.5 |